colab
we are not here to fit in
.png)
designed for
systems change
the cancer collaborative is a catalyst for change — where disruptive ideas and creative strategy come together to challenge systems, influence policy, and drive real impact for people affected by cancer.
THE CO(LABORATORY)
where the work
happens
we look at where cancer care is heading, one, five and ten years out. new tests, new treatments and new technologies keep arriving faster than the system can absorb them. our role is to find the gaps early and bring the right people into the room to work out what needs to change, before those gaps get wider. the goal is a cancer system that works for everyone and is sustainable for the long run.
system reset
2026
this year our work is focused on three areas where we see the biggest opportunity for change. the goal is to identify the gaps, turn what we learn into action, and build what comes next.
experience & evidence
turning what people with cancer live through into evidence the system can act on
precision oncology & diagnostics
building the understanding and the system it takes to deliver on the promise of precision oncology
access & innovation
helping the system keep pace with innovation, and stay sustainable while it does
proof of concept
what we’ve built. what we’re building
the broader impact of patient advocacy
canada's first benchmark of how industry understands and integrates the work of patient organizations.
the constructors
a roundtable series on cancer care in a changing global environment.
patient centricity
what it really means to put patients at the centre of health care, from the role of patients in drug development and innovation to building better patient advocates, and the DISRUPT consensus project.
HER'd
creating space for women in cancer care, starting with were you heard?, a survey on time to diagnosis and how often women were told it was nothing.
crisis to catalyst
what the covid-19 response taught us about prioritizing cancer care.
colab.conversations
our podcast: conversations with the people living, delivering and shaping cancer care in canada.
Beat Cancer Coalition
a coalition working to make advanced molecular testing the norm for every cancer patient in canada, wherever they live.
#KNOWvember
precision oncology awareness month, and a year-round hub on biomarker testing.
cancer policy
our broader cancer policy work, including the cancer paradox paper on what canada invests in cancer research versus what it spends treating cancer, and commentary on fixing canada's cancer system.
CO:DE
turning patient and caregiver experience into ongoing, decision-ready evidence.
DISRUPT
the patient centricity consensus project, with Unum Co.: a national stakeholder survey, a consensus workshop and a shared definition of what patient centricity really means in canada.
car t-cell therapy
from the first roundtable to bring every stakeholder to the table in 2018, through research, advocacy and a webinar series, to letters to governments in 2025: seven years of work on getting CAR T to patients in canada.
PACT
the canadian cancer clinical trials stakeholder charter on patient and patient group engagement in trials, led by PACT.
cancer action now alliance
an alliance of cancer organizations calling for urgent action as canada's cancer system reaches a crisis point.
genomic testing variability across canada
a survey of clinicians on how genomic testing for solid tumours varies across canada.
precision oncology & diagnostics
our work on diagnostic access: strategic priorities for diagnostic access and system innovation in québec, advocacy to protect patient access to liquid biopsy, and who pays for precision oncology diagnostics.
PODs
building a blueprint for precision medicine: a co.laboratory to design canada's precision oncology strategy.
HTA & value
how canada decides what a treatment is worth, and who gets a say: from our 2020 HTA engagement webinars to patient-led consultations, a call to action and a survey on how value is defined.
biosimilars
expanding access through a national conversation on oncology biosimilars.
All.Can
an international initiative on reducing inefficiencies and improving outcomes in cancer care.
bring a problem. we'll bring the table.
our work is built with partners across the system. if you're working on a cancer access issue, we want to hear about it.